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Human pluripotent stem cells (PSCs) exist in naive
and primed states and provide important models to
investigate the earliest stages of human develop-
ment. Naive cells can be obtained through primed-
to-naive resetting, but there are no reliable methods
to prospectively isolate unmodified naive cells during
this process. Here we report comprehensive profiling
of cell surface proteins by flow cytometry in naive
and primed human PSCs. Several naive-specific,
but not primed-specific, proteins were also ex-
pressed by pluripotent cells in the human preimplan-
tation embryo. The upregulation of naive-specific cell
surface proteins during primed-to-naive resetting
enabled the isolation and characterization of live
naive cells and intermediate cell populations. This
analysis revealed distinct transcriptional and X chro-
mosome inactivation changes associated with the
early and late stages of naive cell formation. Thus,
identification of state-specific proteins provides a
robust set of molecular markers to define the human
PSC state and allows new insights into the molecular
events leading to naive cell resetting.
INTRODUCTION
Human pluripotent stem cells (PSCs) exist in multiple states of
pluripotency that are broadly categorized as naive and primed
(Davidson et al., 2015; Weinberger et al., 2016; Wu and Izpisua
Belmonte, 2016). Naive and primed PSCs recapitulate several
developmental properties of the early- and late-stage human
epiblast, respectively, and provide valuable models to investi-Cell Stem Cell 20, 1–
This is an open access article undgate the mechanisms that underpin human pluripotency and
development (Pera, 2014; Rossant and Tam, 2017). Naive
PSCs have been generated by direct derivation from the embryo,
through reprogramming of somatic cells or, more commonly, by
the conversion of conventional primed PSCs (Chan et al., 2013;
Chen et al., 2015; Gafni et al., 2013; Guo et al., 2016; Qin et al.,
2016; Takashima et al., 2014; Theunissen et al., 2014; Ware
et al., 2014). The current protocols used to convert and maintain
naive PSCs vary considerably, resulting in various naive cell
types that differ in their gene expression signatures and other
properties (Huang et al., 2014). Efforts to define pluripotent
states in humans have been challenging, partly because of the
variation in naive cell types and partly because detailed molecu-
lar characterization of human embryos has only recently been
reported (Blakeley et al., 2015; Guo et al., 2014; Okamoto
et al., 2011; Petropoulos et al., 2016; Vallot et al., 2017; Yan
et al., 2013). By benchmarking properties to the human embryo,
a set of standardized molecular criteria to distinguish between
naive and primed PSCs has been proposed based on transcrip-
tional and epigenetic profiles (Huang et al., 2014; Theunissen
et al., 2016). According to these criteria, naive PSCs maintained
in 5 inhibitors, leukemia inhibitory factor (LIF), FGF2 and ActivinA
(5i/L/FA) (Theunissen et al., 2014) and titrated 2i/L+Go¨6983
(titrated 2 inhibitors, LIF and PKC inhibitor [t2i/L+PKCi]) (Taka-
shima et al., 2014) are classified as being similar to the early-
stage human epiblast and are distinct from primed PSCs (Huang
et al., 2014; Theunissen et al., 2016). The proposed criteria can
interrogate cell populations to infer the PSC state; however,
there remains a need to identify standardized markers that are
simple and robust and can unambiguously define individual
pluripotent cell types within a population.
Monitoring changes in cell state and the emergence of new
cell populations are critical for the optimization of protocols
and for understanding the mechanisms underpinning the re-
programming process (O’Malley et al., 2013; Polo et al.,
2012). Primed-state to naive-state PSC conversion generates a17, June 1, 2017 ª 2017 The Authors. Published by Elsevier Inc. 1
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is likely to be naive cells. Current approaches to enrich for a naive
cell population include continued passaging under naive culture
conditions and the gradual selection of converted cells, manual
picking and expansion of individual colonies with characteristic
morphology, and the introduction of reporter transgenes into
the starting cell type (Gafni et al., 2013; Takashima et al., 2014;
Theunissen et al., 2014; Ware et al., 2014). Accurate and trans-
gene-free methods to prospectively identify and isolate naive
PSCs from a heterogeneous population are necessary to track
the emergence of defined cell types and to capture the cells at
earlier stages in their conversion. Two recent studies reported
the characterization of individual cell surface markers that can
be used to examine naive and primed human PSCs. One study
showed that CD24 expression is higher in primed PSCs
compared with naive-like cells, and, in combination with the
pan-human PSC antigen TRA-1-60, low CD24 levels were
used to detect the emergence of a small population of naive-
like cells after more than ten passages under naive conditions
(Shakiba et al., 2015). A second study reported that the levels
of SSEA-4 antigen were low in a subpopulation of naive PSCs
that express the highest levels of naive-specific genes (Pastor
et al., 2016). Thus, SSEA-4 can be used to purify established
naive PSC populations; however, it has not been reported
whether the marker can be used to identify emerging naive cells
during the conversion process. Currently, no cell surface protein
markers that are expressed specifically in naive PSCs have been
reported, and, furthermore, it is likely that a combination of
cell surface protein markers will be required to unambiguously
define PSC states.
Here we describe the results of a large-scale antibody-based
screen in naive and primed PSC lines that led to the identifica-
tion of state-specific cell surface proteins. We validated a
cohort of antibodies in multiple naive and primed PSC lines
and culture conditions and also found that several naive-
specific, but not primed-specific, proteins were expressed in
the pluripotent cells of the human preimplantation embryo.
We developed an antibody panel targeting multiple cell surface
proteins and demonstrated that the panel could distinguish
between naive and primed PSCs, track the dynamics of
naive-primed interconversion, and isolate emerging naive
PSCs from a heterogeneous cell population. The identified
cell surface proteins, therefore, provide a standardized and
straightforward approach to defining and characterizing state-
specific human pluripotent cells.
RESULTS
Cell Surface Protein Profiling in Naive and Primed
Human PSCs
Primed human PSCs (H9 line) were converted and main-
tained in the naive state using two different methods: 5i/L/FA
(Theunissen et al., 2014) and t2i/L+PKCi (Takashima et al.,
2014), to capture any variation related to resetting and growth
conditions (Figure S1). Naive and primed human PSCs were
screened against two commercially available cell surface pro-
tein antibody panels, which generated data for 486 unique
antibodies targeting 377 cell surface proteins (Figure 1A). The
percentage of positive cells was determined for each cell sur-2 Cell Stem Cell 20, 1–17, June 1, 2017face protein, and values from replicates were averaged (Fig-
ure 1B; Table S1).
Providing validation of the experimental approach, our dataset
includes several previously reported cell surface markers that
are expressed in naive and primed human PSCs, including
TRA-1-60 and TRA-1-81 (Chen et al., 2015; Gafni et al., 2013;
Pastor et al., 2016; Qin et al., 2016; Shakiba et al., 2015; Ware
et al., 2014), SSEA-4 as heterogeneously expressed in naive
PSC cultures (Pastor et al., 2016), and CD24 as detected in
primed PSCs (Shakiba et al., 2015). Of the many cell surface
proteins in our dataset that were newly identified as being
expressed in human PSCs, several proteins were detected
in both naive and primed PSCs, including PDPN, MCAM
(CD146), CD151, and CD46, and will provide a useful set of com-
mon markers. The analysis also revealed cell state-specific pro-
teins such as THY1 (CD90), B3GAT1 (CD57), SIRPA (CD172a),
and HLA-A,B,C in primed PSCs and CD75, LAMP2 (CD107b),
CD7, and LY9 (CD229) in naive-state PSCs (Figure 1B). Notably,
the dataset also contained cell state-specific proteins within
important functional classes (Table S1). For example, NOTCH
receptors were detected only in primed-state PSCs, and
the LIF coreceptor (CD130/IL6ST) was detected exclusively in
naive-state PSCs, thereby revealing potential differences in
signaling pathways between the two pluripotent states. The ma-
jority of cell state-specific proteins showed concordant differ-
ences in their transcript levels between naive and primed PSCs
(21 of 33), although many were discordant between protein
and RNA levels, presumably because of post-transcriptional
mechanisms (Figure S2D; Table S1). In addition, several cell
state-specific markers are glycoproteins and other modified epi-
topes that cannot be interrogated through transcriptional
profiling. Overall, our dataset provides a large-scale resource
of cell surface protein expression for naive and primed human
PSCs and could be used in future functional studies to interro-
gate the mechanisms that underpin self-renewal in human
pluripotency.
Validation of Identified Cell Surface Proteins in Multiple
PSC Lines and Human Embryos
We used immunofluorescence microscopy to validate a subset
of the newly identified cell surface proteins in primed and 5i/L/
FA-cultured naive H9 PSCs. Consistent with their expression
profiles obtained from the antibody screen, CD75, CD7, CD77,
and CD130 were detected only in naive PSCs and CD24,
CD57, CD90, and HLA-A,B,C only in primed PSCs (Figure 2A).
In addition, the cell surface protein CD320, which we examined
as a potential marker but is not included in the antibody libraries,
was expressed in naive PSCs but not in primed PSCs, although
some mouse feeder cells showed intracellular staining (Fig-
ure 2A). All proteins showed the expected localization at
the cell surface of PSCs (Figure 2A). We obtained good separa-
tion in fluorescence signal between naive and primed PSCs
using flow cytometry analysis of individual markers with
fluorescence-conjugated antibodies (Figure 2A). Importantly,
we observed similar cell state-specific profiles when comparing
primed and t2i/L+PKCi-cultured naive H9 PSCs, demonstrating
the robustness of the identifiedmarkers (Figure S3A). In contrast,
naive-like cells that were generated using RSeT medium
displayed a different cell surface marker profile, with a
AB
Figure 1. A Resource of Human Naive Cell and Primed PSC Surface Proteins
(A) Overview of the experimental design. Human primed (cultured under knockout serum replacement [KSR]/mouse embryonic fibroblast [MEF] and E8/
Vitronectin conditions) and naive (cultured under t2i/L+PKCi and 5i/L/FA conditions) H9 PSCs were profiled by multiple antibody libraries that targeted 377 cell
surface proteins. Samples were analyzed by high-throughput flow cytometry, and quantification of fluorescence intensity values enabled the identification of
state-specific cell surface proteins. See Figure S1 for characterization of the primed and naive PSCs and Figure S2 for additional details regarding the exper-
imental design.
(B) Summary of the flow cytometry profiling. Each dot represents a different cell surface protein, and their position along the x and y axes is determined by the
percent positive value in naive and primed PSC samples (averaged from one to three independent assays per cell type). Flow cytometry data for naive PSCs
cultured under t2i/L+PKCi and 5i/L/FA conditions were combined. Based on their position in the chart, a subset of cell surface proteins have been categorized as
naive-specific (blue), primed-specific (red), and common to both naive and primed PSCs (green). See Table S1 for the full dataset. The image of the flow cytometer
is provided courtesy of and copyrighted to Becton Dickinson and is reprinted with permission.
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CD90) but no upregulation of naive-specific proteins (Fig-
ure S3B). Together, these results show that our set of identified
cell surface proteins can distinguish between naive cells derived
under different conditions and that complete cell resetting under
specific culture conditions is required to switch on naive-state
cell surface proteins.
The transcriptome of naive PSCs is more similar to cells from
human preimplantation embryos than to primed PSCs (Taka-
shima et al., 2014). To investigate whether our identified proteins
show a similar stage specificity, we analyzed their expression and
localization in embryonic day 6–7 human embryos (Figure 2B). At
this time point, all three lineages of the human blastocyst should
be established (Petropoulos et al., 2016), and this is also
confirmed by the presence of both NANOG-positive epiblast
and NANOG-negative primitive endoderm progenitors within the
inner cell mass (ICM). Using immunofluorescence microscopy,
we could not detect CD7; however, the remaining four naive
PSC-specific markers were all expressed in human blastocysts.
CD75 and CD77 were detected in the whole embryo, including
the ICM, andCD130 andCD320 protein expressionwas enriched
to the ICM, particularly within NANOG-positive epiblast cells (Fig-
ure 2B). In contrast, none of the primed PSC-specific proteins
CD24, CD57, or CD90 were detected in human preimplantation
blastocysts, and HLA-A,B,C was detected only in a few distinct
trophectoderm cells (Figure 2B). To validate the expression of
the primed PSC-specific markers in postimplantation embryos,
we examined a recently published primate transcriptome dataset
(Nakamura et al., 2016). This analysis revealed that CD24, CD57,
and CD90 transcripts are more abundant in postimplantation
epiblast cells compared with preimplantation epiblast cells, sup-
porting their classification as primed state markers (Figure S2E).
In further agreement with the human blastocyst stainings,
CD130 transcriptswere higher inprimatepreimplantationepiblast
cells comparedwith postimplantation, andCD7wasnot detected
at either developmental stage (Figure S2E; CD75 and CD77 are
glycoproteins and cannot be assessed by RNA profiling). Overall,
the immunofluorescence and transcriptional data confirm that
most of the tested naive-specific but few of the primed-specific
markers are expressed in preimplantation-stage embryos. Of
note is that two of the naive PSC markers (CD75 and CD77) are
not localized exclusively in the epiblast but are also present in
extraembryonic cells and, by themselves, should not be consid-
ered as pluripotent-specific markers in human blastocysts.
Nevertheless, taken together, these findings confirm that the
identified PSC-specific markers generally reflect developmental
stage-specific differences in vivo.
An Antibody Panel to Distinguish Between Naive and
Primed Human PSCs
To define a set of cell surface proteins that can discriminate be-
tween naive and primed human PSCs, we designed an antibodyFigure 2. Validation of the Identified Cell Surface Proteins Using Naive
(A) Immunofluorescent microscopy of primed (KSR/MEF) and naive (5i/L/FA) H9
using fluorophore-conjugated antibodies show separation in the fluorescence s
surface proteins. See Figure S3 for an analysis of t2i/L+PKCi-cultured and RSeT
(B) Immunofluorescence microscopy cross-sections of embryonic day 6 human
cell surface markers together with NANOG (to reveal the location of epiblast cellpanel suitable for flow cytometry that multiplexed several of
the validated cell state-specific antibodies: CD75, CD7, CD77,
CD130, CD24, CD57, and CD90 (Figure 3A). We also included
an antibody raised against mouse CD90.2 to detect mouse
feeder cells in the samples and kept the GFP spectra available
to enable the detection of reporter genes. Flow cytometry anal-
ysis showed that combinations of the antibodies can distinguish
between naive and primed PSCs, although the range in marker
expression within each cell population limits the utility of any in-
dividual antibody alone (Figure 3B).
By multiplexing antibodies, we were able to obtain a high-
resolution view of the naive and primed PSCs (Figure 3C). We
visualized the flow cytometry results using FlowSOM (Van Gas-
sen et al., 2015), which concatenates the data and produces
self-organizing maps for clustering and dimensionality reduc-
tion. This approach has the advantages of providing a clear
overview of the expression level of each marker in all cells
and the potential to identify cell subpopulations in an unsuper-
vised manner.
The FlowSOM output for H9 PSCs shows two well separated
cell populations that corresponded to naive and primed cells,
demonstrating that the antibody panel can discriminate between
the two cell states (Figure 3C, right). The individual heatmaps
that are projected onto the self-organizingmap show the expres-
sion levels of each cell surface protein for all cell subpopulations
(Figure 3C, left). CD24, CD57, and CD90 expression levels
are uniformly high in primed PSCs and low in naive PSCs.
Conversely, CD75, CD7, CD77, and CD130 are detected at
high to medium levels in naive PSCs and low levels in primed
PSCs. We confirmed the antibody panel with additional embry-
onic stem cell (ESC) and induced pluripotent stem cell (iPSC)
lines and also under 5i/L/A and t2i/L+PKCi conditions (Figure S4).
Notably, theWIBR3 ESC line carries anOCT4-DPE-GFP reporter
transgene that is active in naive PSCs (Theunissen et al., 2014),
and FlowSOM analysis showed good overlap in the signal
between GFP expression and our naive-specific cell surface
markers, thereby providing added validation for the antibody
panel (Figure S4A).
To more rigorously test the identified protein markers, we
investigated whether the antibody panel could discriminate
between naive and primed PSCs when the cells were mixed
together. We spiked 10% naive PSCs into a sample of primed
PSCs, labeled the mixture with our antibody panel, and analyzed
the cells by flow cytometry. Gating on CD75+/CD130+ cells re-
vealed a population corresponding to the naive PSCs, which
comprised 11% of the sample, suggesting that the majority
of spiked-in naive cells were detected (Figure 3D). This popula-
tion did not express the primed-specific markers CD57 or
CD24. Thus, the antibody panel enables the detection of
state-specific PSCs in a mixed population and opens up the
possibility to prospectively isolate cells during naive-primed
PSC transitions.and Primed PSCs and Human Blastocysts
PSCs for selected cell surface proteins. Histograms of flow cytometry analysis
ignal between primed and 5i/L/FA-cultured naive H9 PSCs for all tested cell
-cultured H9 PSCs. Scale bars, 50 mm.
blastocysts labeled with antibodies that detect the identified naive and primed
s) and the DNA stain Hoechst. Scale bars, 50 mm.
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Naive-Primed PSC Transitions
Naive and primed human PSCs can be interconverted by alter-
ation of culture conditions and reinforced by the short-term
expression of key transcription factors such as NANOG and
KLF2 (Chan et al., 2013; Gafni et al., 2013; Takashima et al.,
2014; Theunissen et al., 2014; Ware et al., 2014). The efficiency
of primed-to-naive PSC resetting is variable between protocols
and cell lines, but in all cases, substantial cell heterogeneity is
generated that could mask the dynamics of cell state changes.
Monitoring the changes in cell state and emergence of new
cell populations is critical for the optimization of protocols and
for understanding the mechanisms underpinning the reprogram-
ming process.
We first studied the dynamics of cell surface protein expres-
sion during naive-to-primed PSC transition (Figures 4A and
4B). Overall, the cell surface markers accurately tracked the
cell state change, and, interestingly, each individual protein ex-
hibited different dynamics during the 10-day time course (Fig-
ures 4C and 4D). For example, CD90 expression increased
sharply within the first 48 hr, whereas upregulation of CD57
was first detected between days 6 and 8. Conversely, CD77
expression was downregulated by day 4, whereas high CD7
and CD130 levels persisted until day 8. Thus, identified cell
surface protein markers can be used to track the dynamics of
PSCs as they undergo cell state change.
We next reset primed H9 PSCs to the naive state using a tran-
sient induction of the NANOG and KLF2 transgenes together
with t2i/L+PKCi medium (Takashima et al., 2014) and analyzed
cell populations by flow cytometry every 48 hr for 10 days (Fig-
ure 5A). The expression levels of the primed-specific marker
CD57 decreased gradually from high to low over 10 days, with
a marked shift occurring as early as day 2 (Figure 5B). In
contrast, increased expression of the naive-specific protein
CD75 occurred at a late stage during resetting, with expression
levels transitioning from low to high between days 8 and 10.
FlowSOM analysis provided additional insights into the dy-
namics of the primed-to-naive state transitions. Interestingly,
the unsupervised self-organizing map staged the cell popula-
tions along an axis that largely recapitulated the time course
from day 2 to day 10 (Figure 5C). This finding suggests that
each time point has a distinct and ordered cell surface protein
signature. The FlowSOM heatmaps reveal changes in cell sur-Figure 3. An Antibody Panel to Distinguish between Naive-State and P
(A) A list of antibodies that are combined to form a multiplexed panel. The infor
Table S4 for antibody details and Table S5 for flow cytometer parameters.
(B) Flow cytometry contour plots of pairwise antibody combinations. The primed
primed-specific (bottom) markers are on the x axes. Primed (red) and t2i/L+PKCi
Figure S4A for flow cytometry plots that exemplify a typical complete gating schem
in naive PSCs compared with the other markers but is still useful when used in c
(C) FlowSOM visualization of flow cytometry data for all antibodies in the panel. An
by circles) according to similarities in their cell surface protein expression profiles
separation of naive (blue) and primed (red) populations. The heatmap panels (le
Clusters are arranged in the same position as for the minimal spanning tree of the
and iPSC lines.
(D) Flow cytometry contour plots show that the identified panel of state-specific
mixed together. Left: the expression levels of two naive-specific proteins (CD130 a
levels of the same proteins in a sample of 90% primed + 10% naive PSCs. Bottom
and CD24. Gates were drawn based on unstained, live, human PSCs.face protein expression levels during the transition (Figure 5C).
For example, CD7 and CD130 are upregulated rapidly upon
primed-to-naive transition and reached maximal levels by
day 4. CD77 is upregulated more gradually, starting from day 6
onward, andCD75 is upregulated at a late stage during resetting.
The primed-specific markers, CD24 and CD90, were downregu-
lated rapidly upon primed-to-naive resetting, and CD57 shifted
gradually from high to low over the 10 days. Notably, the greatest
spread in the self-organizing map occurred on day 10, reflecting
high cellular heterogeneity at this time point. A subset of day 10
cells, however, clustered closely with established naive cells and
were likely to be the newly formed naive cells that we charac-
terize in detail in the next sections.
We monitored primed-to-naive resetting using an additional
PSC line (WIBR3) and with a transgene-free conversion protocol
using 5i/L/A medium (Theunissen et al., 2014). Overall, the cell
surface protein markers behaved in a very similar manner (Fig-
ure 5D). Interestingly, the efficiency of resetting was noticeably
greater using this protocol, and this is reflected by the majority
of day 10 cells that are positioned closely to the established
naive cells, with a smaller population of day 10 cells that cluster
away from naive PSCs. Further validation is provided by the
OCT4-DPE-GFP reporter signal, which closely overlaps with
our naive-state cell surface protein markers (Figure 5D). Taken
together, these studies have identified a panel of cell surface
protein markers that are able to distinguish between naive and
primed human PSCs during differentiation and resetting and
thereby provide new ways to investigate the dynamics of cell
state transitions.
Identified Cell Surface Proteins Allow the Prospective
Isolation of Early-Stage Naive Cells and the Generation
of Naive PSC Lines
Primed-to-naive human PSC resetting is an inefficient and vari-
able process and is, therefore, dependent on the accurate
detection and isolation of the emerging naive cells. Defining
and characterizing partially reprogrammed and intermediate
cell states can also provide important insights into the trajec-
tories and mechanisms of cell state changes, as has been
demonstrated in iPSC reprogramming (O’Malley et al., 2013;
Polo et al., 2012). We investigated whether the cell surface pro-
tein markers could prospectively isolate naive cells upon reset-
ting and also capture the cells at an earlier stage in the resettingrimed-State Human PSCs
mation in brackets shows the fluorophore conjugation of each antibody. See
-specific marker CD57 is on the y axes, and different naive-specific (top) and
-cultured naive (blue) H9 PSCs are shown for each antibody combination. See
e for H9 naive PSCs. Note that CD77 shows a greater degree of heterogeneity
ombination.
unsupervised self-organizing map arranges the cells into clusters (represented
(right). Overlaying the identity of the cell type within each cluster reveals a clear
ft) show the expression level of each cell surface protein in the cell clusters.
self-organizing map. See Figures S4B and S4C for analyses of additional ESC
markers can discriminate between primed and naive PSCs when the cells are
nd CD75) in primed (top) and naive (bottom) H9 PSCs. Top right: the expression
right: CD75+/CD130+ cells do not express the primed-specific markers CD57
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time course experiments described above, we focused on day
10 cells during primed-to-naive resetting. We applied the cell
surface antibody panel to the cell population and used cell sort-
ing to isolate cells that expressed all naive-specific protein
markers at high levels and were low/off for all primed-specific
markers. This population, designated as naive-like cells (N4+),
represented 1% of the total sample (Figures 6A and 6B). For
comparison, we also isolated two other cell populations, desig-
nated asN3+ (CD7+, CD77+, CD130+, andCD75–) andN4– (nega-
tive for all four naive-specific markers), representing 6% and
22% of the cell population, respectively (Figures 6A and 6B).
Similar cell populations were observed for WIBR3 PSCs using
5i/L/A-mediated conversion, although, of note, the proportion
of N4+ naive-like cells in the day 10 sample was substantially
larger (14%; Figure S5A).
We examined the gene expression profiles of the sorted pop-
ulations using qRT-PCR. The expression levels of pluripotency
factors (POU5F1, SOX2, and NANOG) and naive-specific genes
(KLF17, KLF4, TFCP2L1, DPPA3, and DNMT3L) were similar in
N4+ cells and established naive PSCs (Figure 6C). As expected,
primed-specific genes (DUSP6, OTX2, and ZIC2) were barely
detectable in N4+ and naive PSCs. Interestingly, the N3+ gene
expression profile was close to the N4+ and naive PSC profiles,
with the exception that KLF17 levels were significantly lower by
40-fold (Figure 6C). This finding suggests that N3+ cells, which
lack CD75 expression, may represent a partially reset cell type,
and that KLF17 is likely to be fully upregulated at the later stages
of naive cell formation. In contrast, N4– cells did not display a
pluripotent cell gene expression signature, but, instead, their
gene expression profile more closely resembled neural-like cells
with high levels of SOX2,OTX2, and ZIC2 transcripts (Figure 6C).
Neural differentiation is consistent with the known response of
primed human PSCs to fibroblast growth factor (FGF) inhibitors
(Greber et al., 2011), which is one of the components in the
resetting medium.
To further characterize the different cell populations, sorted
cells were transferred directly into naive PSCs culture condi-
tions, and cell colony morphology was scored after 4 days.
The majority of colonies derived from N4+ cells were scored
as naive-like, with a characteristic compact and domed
morphology (344 of 538 colonies, 64%; n = 4; Figure 6D). This
proportion is not significantly different from the number of
naive-like colonies obtained after plating established naive
PSCs under the same conditions (328 of 431, 76%, n = 3). In
contrast, significantly fewer naive-like colonies were generated
from N3+ cells (100 of 220, 45%, n = 4), providing further evi-
dence that these cells are likely to be partially reset. Notably,Figure 4. Cell Surface Protein Expression Levels Track the Dynamics
(A) Overview of the experimental design. Shown is a time course experiment of P
cytometry analysis every 48 hr.
(B) Phase contrast images of H9 PSCs reveal the morphological changes that oc
Scale bars, 100 mm.
(C) Flow cytometry dotplots of pairwise antibody combinations over the time cours
and naive-specific markers on the x axis (CD75, top; CD130, bottom).
(D) FlowSOM visualization of the flow cytometry time course data for H9 PSCs. T
clustering of the samples based on their cell surface protein expression levels (rig
during conversion from the naive state to the primed state. The heatmap shows tno naive-like colonies and only four primed-like colonies formed
from N4– cells (Figure 6D), which is consistent with their pre-
dicted neural fate. Colonies generated from the N4+ cells were
positive for KLF17 and OCT4 by immunofluorescence micro-
scopy, confirming their status as naive PSCs (Figure 6E). We
continued to maintain N4+ cells under naive PSC culture condi-
tions for over 20 passages, and the cells generated stable naive
PSC lines (Figure 6F). We obtained similar results using the
WIBR3 PSC line under 5i/L/FA conditions (Figure S5B).
Multiplexing a large panel of antibodies provides a high-reso-
lution analysis of cell populations but comes with challenges
related to ease of use and the availability of suitable flow cytom-
etry equipment. To improve the usability of our approach, we
refined the set of antibodies and found that a combination
of two naive-specific markers (CD75 and CD130) and two
primed-specific markers (CD24 and CD57) could largely recapit-
ulate the full antibody panel. We used this minimal panel to inter-
rogate cells on day 10 of resetting and used cell sorting to isolate
cells that were CD75/CD130high and CD24/CD57low (Figures
S5C and S5D). This population was designed as Nminand repre-
sented 3% of the total sample. Transcriptional analysis of Nmin
cells revealed a gene expression signature that was similar to
N4+ and naive PSCs (Figure 6C). Furthermore, the cells gave
rise to predominantly naive-like colonies in culture (299 of 395,
76%, n = 3) and could form stable naive PSC lines that were
KLF17- and OCT4-positive (Figures 6D–6F). Taken together,
our results demonstrate that the cell surfacemarkers can identify
newly formed naive PSCs from a heterogeneous resetting cell
population and that the isolated cells can give rise to established
naive PSC lines.
Distinct Transcriptional andXChromosome Inactivation
Changes Associatedwith Early and Late Stages of Naive
PSC Formation
We used RNA sequencing to assess the transcriptional state of
the isolated cell populations and compared them with estab-
lished naive and primed PSC lines. Clustering by principal-
component analysis (PCA) revealed that N4+ and Nmin cells
cluster closely to established naive PSCs along the first principal
component, which captures 72%of the variation in gene expres-
sion (Figure 7A, left). In contrast, N4– cells cluster closer to
primed PSCs. The second principal component (capturing
16% of the variation) separates the day 10-isolated populations
from the established PSC lines, suggesting that the day 10 sam-
ples represent early-stage cell types that have not fully acquired
amature gene expression profile (Figure 7A). To explore this idea
further, we profiled isolated N4+ cells that were maintained
for five passages (P5) and ten passages (P10) in t2i/L+PKCi.of Naive-to-Primed PSC Transition
SCs undergoing a transition from the naive state to the primed state, with flow
cur during naive state-to-primed state transition under t2i/L+PKCi conditions.
e. Shown are primed-specificmarkers on the y axis (CD57, top; CD90, bottom)
he minimal spanning tree of the self-organizing map displays an unsupervised
ht). The results reveal a progressive change in cell surface protein expression
he expression level of each cell surface protein marker in the cell clusters (left).
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naive PSCs, which demonstrates that the transcriptional pro-
gram of N4+ cells undergoes a final maturation phase over the
first few passages under naive culture conditions (Figure 7A).
Examination of genes that contribute to the first principal
component reveals the influence of known naive-specific (such
as TFCP2L1, DPPA3, and KLF4) and primed-specific (such as
DUSP6, OTX2, and ZIC2) genes in segregating the cell clusters
(Figure 7A, right). In addition, the influence of genes such as
NR2F2, DKK1, and SOX5 confirm that N4– cells display a strong
neural gene expression signature (Figure 7A). More interestingly,
genes that contribute to the second principal component pro-
vide new insights into the potential transcriptional differences
between early-stage and late-stage naive cells (Figure 7A). For
example, genes associated with early-stage N4+ cells include
TBX3, DPPA3, FGF18, and FOXC1, and genes associated with
late-stage established naive cells include XIST, MEG3, and
ZNF729. Gene ontology (GO) analysis of transcripts that are up-
regulated in naive PSCs compared with N4+ cells revealed a
significant enrichment for biological processes related to the
regulation of transcription (Figure 7B, top). Strikingly, almost
half of the genes within this GO category encode zinc finger
proteins (n > 100), suggesting that this class of transcriptional
regulator may be associated closely with cell state. Transcripts
downregulated in naive PSCs compared with N4+ cells are
significantly enriched for GO terms related to developmental
and differentiation regulators (Figure 7B, bottom). This finding
implies that genes potentially involved in lineage priming are
robustly silenced during the later stages of naive PSC formation.
Taken together, characterization of newly defined cell popula-
tions at an early stage in primed-to-naive conversion reveals
the transcriptional changes that are associated with naive cell
formation and maturation.
Several molecular criteria, including X chromosome status and
transposable element (TE) expression, have recently been pro-
posed to provide an accurate approach to distinguish between
naive and primed PSCs (Petropoulos et al., 2016; Sahakyan
et al., 2017; Theunissen et al., 2016; Vallot et al., 2017). We
examined our RNA sequencing (RNA-seq) datasets to determine
the allele-specific expression of X-linked genes and then classi-
fied informative transcripts as monoallelic or biallelic. This anal-
ysis revealed that X chromosome reactivation occurred primarily
during the late-stage maturation of naive cells (Figure 7C) and
supports the conclusion that X chromosome reactivation is a
robust molecular marker of mature naive PSCs. Curiously, this
analysis also identified a set of 14 genes on the p arm that
were expressed biallelically in the P5 and P10 cells but monoal-
lelically in the established naive PSCs. The reason for thisFigure 5. Monitoring the Dynamics of Primed-State to Naive-State PSC
(A) Phase contrast images of H9 PSCs reveal the morphological changes that occ
Doxycycline-inducibleNANOG and KLF2 transgenes were activated for the first 8
bars, 100 mm.
(B) Flow cytometry dotplots of pairwise antibody combinations over the time cours
and naive-specific markers on the x axis (CD75, top; CD130, bottom).
(C and D) FlowSOMvisualization of the flow cytometry time course data for (C) H9 P
that 5i/L/A conversion is transgene-free and that 5i/L/A was added on day 1. Th
clustering of the samples based on their cell surface protein expression levels (righ
in the cell clusters (left).difference is currently unclear but could indicate an erosion of
X chromosome activation during long-termmaintenance of naive
PSCs.
We next investigated the transcription of TEs in the isolated
cell populations (Table S3). Clustering of the samples by PCA
positioned the N4+ cells in between the established primed
and naive PSCs, which reinforced our previous result that the
day 10 samples represent early-stage cell types that have not
fully acquired mature expression profiles (Figure 7D, left). In sup-
port of this finding, the P5 and P10 samples clustered closely to
the established naive PSCs (Figure 7D). Interestingly, the load-
ings plot (Figure 7D, right) and clustering analysis (Figure S6)
reveal the specific TE families that contribute the most to each
sample. In particular, known naive-specific (such as the SVA
classes of repeats) and primed-specific (such as LTR7 and
HERVH-int) transcripts segregate the first principal component
(Figure 7D, right; Theunissen et al., 2016). Moreover, the analysis
also identified TE families that may help to characterize early-
stage naive cells (such as LTR7Y, LTR5B, and HERV9NC-int)
and late-stage naive PSCs (such as MER47C, MER57E3, and
BSR/Beta). Taken together, our identified set of cell surface
markers and cell sorting strategy have enabled the definition of
distinct transcriptional and X chromosome inactivation events
associated with naive cell resetting.
DISCUSSION
We present here the results of a comprehensive antibody screen
of cell surface proteins in naive and primed human PSCs. This
approach enabled the definition of state-specific cell surface
protein signatures that are robust across multiple human PSC
lines and culture conditions. The proposed signatures can be
applied to interrogate cell populations to infer PSC state. Advan-
tages of this approach over molecular criteria to distinguish
between naive and primed PSCs (Theunissen et al., 2016)
include the examination of live cells and compatibility with down-
stream functional assays and the ability to unambiguously cate-
gorize individual pluripotent cell types within a population.
Several of the naive-specific but not primed-specific proteins
were expressed in preimplantation-stage human embryos,
including in pluripotent epiblast cells. This validation provides
further reassurance that the naive PSCs resemble human plurip-
otent cells in vivo, which is in line with previous transcriptional
and epigenetic comparisons (Blakeley et al., 2015; Guo et al.,
2014; Okamoto et al., 2011; Petropoulos et al., 2016; Theunissen
et al., 2016; Vallot et al., 2017; Yan et al., 2013). Nevertheless,
differences in protein expression (such as CD7) also raise the
possibility that naive PSCs may not entirely recapitulate theConversion Using Cell Surface Protein Markers
ur during primed-state to naive-state conversion under t2i/L+PKCi conditions.
days in t2i/L, and then doxycycline was withdrawn and PKCi was added. Scale
e. Shown are primed-specificmarkers on the y axis (CD57, top; CD24, bottom)
SCs under t2i/L+PKCi conditions and (D)WIBR3 under 5i/L/A conditions. Note
e minimal spanning trees of the self-organizing maps display an unsupervised
t). The heatmap shows the expression level of each cell surface protein marker
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research is required to equate PSCs to specific developmental
stages. As an initial step, our dataset uncovered several insights
that are relevant for the investigation of early-stage human devel-
opment. To exemplify the application of our dataset to human
embryos, we demonstrated that the naive-specific protein
CD130 (the LIF co-receptor) is expressed in the human epiblast.
Although the role of LIF signaling in mouse development and
mouse PSC self-renewal is well established (Ohtsuka et al.,
2015; Onishi and Zandstra, 2015), the function of this pathway
is poorly understood in human development and PSCs. There
are conflicting reports about the expression of LIF signaling
components in primed PSCs (Brandenberger et al., 2004; Car-
penter et al., 2004; Dahe´ron et al., 2004; Humphrey et al.,
2004), and our work, therefore, provides an impetus for future
characterization of this signaling pathway.
Our screening approach enabled us to develop a multiplexed
panel of state-specific antibodies that we applied to several crit-
ical problems currently encountered during human PSC reset-
ting and differentiation. We first investigated the dynamics of
naive-state and primed-state interconversions, which confirmed
the utility and specificity of the protein markers and extended our
understanding of these cellular processes. In particular, moni-
toring the changes in cell-surface protein expression allowed
the tracking of cell populations and the comparison of different
resetting protocols. For example, the proportion of day 10-reset
cells with similar protein signatures to established naive PSCs
and the timing in the emergence of this cell population were
increased under the 5i/L/A conditions compared with t2i/
L+PKCi (Takashima et al., 2014; Theunissen et al., 2014). These
comparative observations should be useful for the further devel-
opment of resetting protocols. We also observed differences in
the dynamics of each protein marker during a resetting time
course. For example, the expression levels of proteins such as
CD90 changed rapidly during cell state transitions and are likely
to be responsive to cell culture conditions. In contrast, other pro-
teins changed expression more gradually, such as CD130 and
CD57, and are therefore more sensitive indicators of cell state.
Multiplexing antibodies enabled a high-resolution analysis ofFigure 6. Prospective Isolation of Early-Stage Naive Cells
(A) Flow cytometry dotplots of day 10 cells during primed-state to naive-state con
specific markers, CD75 and CD77. Based on unstained, live, human day 10 samp
(green box), CD75–/CD77+ (orange box), and CD75–/CD77– (purple box) cell pop
cell populations. Boxed areas indicate the N4+ (green), N3+ (orange), and N4– (p
centage of cells within each cell sorting gate relative to all live, human cells is show
exclude primed-state markers. See Figure S5C for the Nmin gating strategy.
(B) FlowSOM visualization of the flow cytometry data for day 10 cells during prim
displays an unsupervised clustering of the sample based on the cell surface p
population, N4+, N3+, and N4–, are indicated. The heatmap shows the expression
for FlowSOM visualization of WIBR3 PSCs on day 10 of primed state-to-naive st
(C) qRT-PCR analysis of gene expression levels in the different cell-sorted popula
relative to primed PSCs. Data show the mean ± SD of three or four biological re
Dunnett’s multiple comparisons test (*p < 0.05, **p < 0.005, ***p < 0.0005).
(D) Scoring of colony morphology after transferring the different cell-sorted popu
primed, and differentiated; examples are shown below. Data show the mean ± SD
PSCs using an ANOVA with Dunnett’s multiple comparisons test (*p < 0.05, **p <
(E) Immunofluorescence microscopy for KLF17 (a naive-specific protein) and OC
cell-sorted populations can generate KLF17+/OCT4+ colonies that are similar to
(F) Phase contrast images showing representative fields of view of N4+ and Nmin c
conditions for three passages. Scale bars, 100 mm. See Figure S5B for similar recell samples and was able to reveal discrete subpopulations
of cells when visualized by dimensionality reduction methods
such as FlowSOM (Van Gassen et al., 2015). We suggest that
the identified proteins could also be used to study other reprog-
ramming events, such as the conversion of somatic cells to naive
iPSCs, or to identify naive PSCs in a screen for naive-promoting
factors.
Although the focus of the current study was to identify proteins
that can distinguish between naive and primed human PSCs, the
availability of an extensive catalog of proteins present on the cell
surface of PSCs should also be valuable for the study of human
pluripotency and differentiation. In particular, differences in
cell surface protein expression raise the possibility that some
of the markers may have a role in regulating PSC state. For
example, CD75, which was upregulated at a late stage of
primed-to-naive resetting, is a cell surface glycoprotein that is
catalyzed by sialytransferases (Munro et al., 1992). Sialylation
is involved in a variety of cellular functions, such as cell adhesion,
signal recognition, and modulation of glycoprotein stability
(Pshezhetsky and Ashmarina, 2013; Schauer, 2009). A previous
study demonstrated that perturbation of the sialtransferase
ST6GAL1 results in less efficient reprogramming of somatic cells
and compromised self-renewal of human primed PSCs (Wang
et al., 2015). However, sialtransferase activity and function and
the role of the glycoprotein CD75 have not been examined in
naive PSCs, and this provides one interesting direction for future
investigation. Other proteins identified in our screen included
several NOTCH receptors that were expressed exclusively in
primed PSCs. NOTCH signaling is crucial for many aspects of
stem cell regulation, including cell fate decisions and cell prolif-
eration (Perdigoto and Bardin, 2013). It will, therefore, be inter-
esting to investigate whether proteins identified in our screen
have a functional role in naive or primed pluripotency. Last, an
additional line of future work to enhance our resource could be
the application of proteomics, including phosphoproteomics,
to the two human PSC-types to obtain a comprehensive over-
view of protein expression and pathway activity.
Previous studies have relied on transgene expression or the
judgement of cell morphology to detect and select naive PSCsversion of H9 PSCs under t2i/L+PKCi conditions. Left: the levels of two naive-
les, three cell sorting gates have been drawn that correspond to CD75+/CD77+
ulations. Right: the levels of CD7 and CD130 proteins for the same three gated
urple) cell populations that were used for subsequent experiments. The per-
n. Note that the values do not take into account additional gates; for example, to
ed to naive conversion. The minimal spanning tree of the self-organizing map
rotein expression levels (right). The cells corresponding to each cell sorting
level of each cell surface proteinmarker in the cell clusters (left). See Figure S5A
ate conversion and Figure S5D for FlowSOM visualization of Nmin cells.
tions and established naive PSCs. Expression levels are shown on a log scale
plicates and were compared to established naive PSCs using an ANOVA with
lations into naive PSC conditions. Colonies were categorized as naive, mixed,
of three or four biological replicates and were compared to established naive
0.005, ***p < 0.0005). Scale bars, 100 mm.
T4 (a protein expressed by naive and primed PSCs) reveals that N4+ and Nmin
established naive PSCs. Scale bars, 100 mm.
ell-sorted populations that have been propagated under t2i/L+PKCi naive PSC
sults using WIBR3 PSCs under 5i/L/FA conditions.
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Figure 7. Distinct Molecular Changes during Naive Cell Formation
(A) PCA of RNA-sequencing gene expression data from the different cell-sorted populations (left). Right: the contribution of selected genes to the first and
second PCs.
(B) TopGO terms of genes that were differentially expressed between N4+ and established naive PSCs. Numbers of genes are shown; example genes within each
GO category are listed (right). Corrected p values were calculated using a modified Fisher’s exact test followed by Bonferroni’s multiple comparisons test. See
Table S2 for the full dataset.
(C) Schematic of X chromosomes that summarize the results from an allelic analysis of RNA-seq data for the indicated cell types. Informative SNPswithin X-linked
genes of the H9 PSC line (Vallot et al., 2017) were used to classify expression as monoallelic (brown, <25% from minor allele), biallelic (orange, 25%–75% from
minor allele), or not expressed (gray, <10 reads/sample). The number of monoallelic and biallelic genes is shown below.
(D) PCA of TE classes from the different cell-sorted populations (left). Right: the contribution of TEs to the first and second PC. Selected TEs are labeled as having
a previously defined naive (blue) or primed (red) TE signature (Theunissen et al., 2016).
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Theunissen et al., 2014; Ware et al., 2014). In contrast, our set
of cell surface markers can identify and prospectively isolate
the emerging naive cells from a heterogeneous population of
resetting cells, thereby enabling an unambiguous and straight-
forward approach to derive naive PSC cultures. This approach
also allows the examination of specific cells at a time point
much earlier in the resetting process than was previously
possible. Our molecular characterization of cells on day 10 of
resetting showed that their transcriptome was more similar to
naive cells than to primed cells but not identical to established
naive PSCs. Importantly, this analysis provided new insights
into the temporal sequence of gene expression changes. In
particular, we found that the transcription factors KLF17,
DPPA5, and NANOG are induced at a relatively late stage
of resetting, but other genes, such as DPPA3 and TBX3, are
induced earlier. Conversely, the process of X chromosome reac-
tivation and the expression of several genes that define estab-
lished naive cells such as MEG3, XIST, and a large set of zinc
finger proteins, have not been induced by day 10. Through this
approach, we can begin to observe the temporal sequence of
molecular events that are triggered during cell resetting, thereby
providing a first step toward mapping the route of PSC state
transitions. Thus, our work generates an important resource of
cell surface proteins in naive and primed PSCs and provides a
framework for the future investigation of human pluripotency.STAR+METHODS
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Institute
CAS: 391210-10-9
WH-4-023 A Chemtek Cat#0104-002013; CAS: 837422-57-8
IM-12 Sigma-Aldrich Cat#SML0084; CAS: 1129660-05-1
SB590885 Sigma-Aldrich Cat#SML0501; CAS: 405554-55-4
Y-27632 Millipore Cat#688000; CAS: 146986-50-7
CHIR99021 WT-MRC Cambridge Stem Cell
Institute
CAS: 252917-06-9
Go¨6983 Tocris Cat#2285; CAS: 133053-19-7
Critical Commercial Assays
BD Lyoplate Human Cell Surface Marker
Screening Panel
BD Biosciences Cat#560747
LEGENDScreen Human Cell Screening Kit BioLegend Cat#700001
Deposited Data
RNA-seq data deposited to Gene
Expression Omnibus
This paper GEO: GSE93241
Human reference genome NCBI build 38,
GRCh38
Genome Reference Consortium http://www.ncbi.nlm.nih.gov/projects/
genome/assembly/grc/human/
RNA-sequencing data used for calling
concordant expression between gene
and protein levels (related to Figure S2
and Table S1)
Takashima et al., 2014 ArrayExpress: E-MTAB-2857
Primate transcriptional data from Gene
Expression Omnibus (related to Figure S2E)
Nakamura et al., 2016 GEO: GSE74767
Positions of heterozygous SNPs on the
X-chromosome of H9 cells (related to
Figure 7)
Provided by Celine Vallot;
Vallot et al., 2015
N/A
Experimental Models: Cell Lines
WA09/H9 primed PSCs WiCell WA09
WA09/H9 NK2 naive and primed PSCs Laboratory of Austin Smith;
Takashima et al., 2014
N/A
WA09/H9 FiPS naive and primed PSCs Laboratory of Austin Smith;
Takashima et al., 2014
N/A
WIBR3 naive and primed PSCs Laboratory of Rudolph Jaenisch;
Theunissen et al., 2014
N/A
Recombinant DNA
piggyBac transposon vector Zhang et al., 2015 N/A
piggyBac EGFP transposase vector Zhang et al., 2015 N/A
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Sequence-Based Reagents
For primer sequences, please see Table S6
NEBNext Ultra RNA Library Prep Kit NEB E7530
Poly(A) mRNA Magnetic Isolation Module NEB E7490
Software and Algorithms
FlowJo V10.1 FlowJo LLC https://www.flowjo.com/solutions/flowjo
FlowAI V1.2.4 Monaco et al., 2016 https://www.bioconductor.org/packages/
release/bioc/html/flowAI.html
FlowSOM V1.2.0 Van Gassen et al., 2015 https://www.bioconductor.org/packages/
release/bioc/html/FlowSOM.html
HISAT 2.0.5 Kim et al., 2015 https://ccb.jhu.edu/software/hisat2/
index.shtml
Seqmonk v36.0 Babraham Institute, Bioinformatics http://www.bioinformatics.babraham.ac.
uk/projects/seqmonk/
DESeq2 Love et al., 2014 https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
ImageJ ImageJ https://imagej.nih.gov/ij/
Ensembl Genome Browser v70 Aken et al., 2017 http://www.ensembl.org/index.html
Trim Galore v0.4.2 Babraham Institute, Bioinformatics http://www.bioinformatics.babraham.
ac.uk/projects/trim_galore/
Samtools Li et al., 2009 http://samtools.sourceforge.net/
SNPsplit v0.3.1 Krueger and Andrews, 2016 https://github.com/FelixKrueger/SNPsplit
AmiGO 2 Carbon et al., 2009 http://amigo.geneontology.org/amigo
GraphPad Prism 7 GraphPad Software https://www.graphpad.com/
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Fredrik
Lanner (fredrik.lanner@ki.se).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
WA09/H9 primed cells were obtained from WiCell. WA09/H9 NK2 and FiPS naive and primed PSCs were kindly provided by Austin
Smith (Takashima et al., 2014) with permission from WiCell. Naive and primed WIBR3 PSCs were kindly provided by Rudolph Jae-
nisch (Theunissen et al., 2014). All PSCs were cultured in 5% O2, 5% CO2 at 37
C.
Embryos
Human embryos were obtained from the Karolinska University Hospital, Huddinge and from the Carl von Linne´ Clinic, Uppsala, either
frozen at embryonic day (E) 2 or from preimplantation genetic diagnosis testing at E4, with informed consent from donating couple
and with ethical approval for these experiments to F.L. from the Regional Ethics Board, Stockholm (2012/1765-31/1). Frozen em-
bryos were thawed with ThawKit Cleave (Vitrolife) into G-1 Plus medium (Vitrolife) covered with Ovoil (Vitrolife) and from E3 embryos
were cultured in G-2 Plus medium until E6-7 in 5% O2, 5% CO2 at 37
C.
METHOD DETAILS
Cell culture
Primed PSCs were maintained in DMEM/F12, 20% Knockout Serum Replacement, 1% nonessential amino acids, 2mM GlutaMAX,
50 U/ml and 50 mg/ml penicillin-streptomycin (all from ThermoFisher Scientific), 0.1mM b-mercaptoethanol (Millipore), and 4–8ng/ml
basic fibroblast growth factor (bFGF; R&D Systems) on irradiated mouse embryonic fibroblasts (MEF) seeded at a density of 1x106
cells per 6-well plate. Cells were passaged by 5min incubation with 200U/ml Collagenase type IV (ThermoFisher Scientific). For
feeder-free culture, primed PSCs were transferred onto Vitronectin-coated plates (0.5mg/cm2; ThermoFisher Scientific) in complete
TeSR-E8 or mTeSR1 medium (StemCell Technologies). Cells were passaged by 6min incubation at room temperature with Gentle
Cell Dissociation Reagent (StemCell Technologies).e3 Cell Stem Cell 20, 1–17.e1–e7, June 1, 2017
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mixture of DMEM/F12 and Neurobasal, 1x N2-supplement, 1x B27-supplement, 1% nonessential amino acids, 2mM GlutaMAX,
50 U/ml and 50 mg/ml penicillin-streptomycin (all from ThermoFisher Scientific), 0.1mM b-mercaptoethanol (Millipore), 50 mg/ml
bovine serum albumin (Sigma), 0.5% Knockout Serum Replacement, 20ng/ml recombinant human LIF (Millipore), 20ng/ml Activin
A (R&D Systems), 8ng/ml bFGF (omitted in 5i/L/A conditions), 1 mM PD0325901 (Sigma), 1 mM IM-12 (Sigma), 1 mM WH-4-023
(A Chemtek), 0.5 mMSB590885 (Sigma), 10 mMY-27632 (Millipore) on aMEF-layer seeded at a density of 2x106 cells per 6-well plate.
Cells were passaged with 5min incubation with Accutase (ThermoFisher Scientific). Naive PSCs cultured in t2i/L+PKCi conditions
were maintained as previously described (Takashima et al., 2014) in a 1:1 mixture of DMEM/F12 and Neurobasal, 0.5x N2-supple-
ment, 0.5x B27-supplement, 1x nonessential amino acids, 2mM L-Glutamine, 1x Penicillin/Streptomycin (all from ThermoFisher
Scientific), 0.1mM b-mercaptoethanol (Sigma-Aldrich), 1 mM PD0325901, 1 mM CHIR99021, 20ng/ml human LIF (all from
WT-MRC Cambridge Stem Cell Institute) and 2 mM Go¨6983 (PKCi; Tocris) on a MEF-layer seeded at a density of 2x106 cells per
6-well plate. For feeder-free culture, t2i/L+PKCi naive PSCs were cultured on Matrigel–coated plates (Corning).
For conversion to 5i/L/FA and 5i/L/A naive PSCs, primed PSCs were dissociated into single cells with Accutase and 2x105 cells
per 6-well were plated in primed PSC media with 10 mM Y-27632 onto MEF seeded at a density of 2x106 cells per 6-well plate.
The following day, media was changed to 5i/L/FA or 5i/L/A media. Dome-shaped naive colonies could be seen as early as four
days after plating, and cells were passaged with Accutase on day 6 for 5i/L/A cells, and on day 10 for 5i/L/FA cells.
For conversion to t2i/L+PKCi naive PSCs, primed H9 NK2 PSCs were dissociated into single cells with Accutase and 2x105 cells
per 6-well were plated in primed PSC media with 10 mM Y-27632 onto MEF seeded at a density of 2x106 cells per 6-well plate. The
following day (day 1), media was changed to primed PSC media with 1 mg/ml doxycycline (DOX). On Day 2, media was changed for
2i/L+DOX media and replaced daily until day 8 where media was changed to t2i/L+PKCi. Cells were passaged using Accutase on
day 3 (1:5 ratio) and day 7 (1:3 ratio).
Conversion of primed H9 NK2 PSCs to naive-like PSCs in RSeT media was achieved following the manufacturer’s manual
(StemCell Technologies). This media formation is based on a bFGF– and TGFb–free version of NHSM (Gafni et al., 2013). Cells
were assayed after 4 passages in RSeT conditions.
For transition to primed PSCs, 5i/L/FA-cultured naive PSCs were dissociated into single cells with Accutase and 2x105 cells per
6-well were plated in 5i/L/FA naive PSCmedia onto MEF seeded at a density of 1x106 cells per 6-well plate. The following day, media
was changed to primed PSC media. Flat primed PSC colonies could be seen as early as four days after plating and cells were
passaged around 10 days after plating using Collagenase type IV. For transition to primed PSCs, t2i/L+PKCi-cultured naive PSCs
maintained in feeder-free conditions were dissociated into single cells with Accutase, and 2x105 cells per 6-well were plated in
t2i/L+PKCi naive PSC media onto Matrigel-coated 6-well plates. Two days later (day 0), media was changed to complete mTeSR1
medium. Cells were passaged on day 4 using Accutase for the first passage, and Collagenase type IV for subsequent passages.
GFP transfection
For establishing stable GFP expressing cells, primed H9 PSCs were cultured on plates coated with human PSC-qualified Matrigel in
mTeSR1 medium. Cells were co-transfected in a 6-well format with 2.5 mg piggyBac transposon and 2.5 mg EGFP transposase vec-
tors (Zhang et al., 2015) using 10 mL Lipofectamine LTX (ThermoFisher Scientific) and 5 mL PLUS reagent (ThermoFisher Scientific)
according to the manufacturer’s instructions. 48h after transfection, selection with 1 mg/ml puromycin (ThermoFisher Scientific) was
started for a 6-day period. Transfected cells were transferred back onto MEFs and maintained in primed PSC culture conditions or
converted into 5i/L/FA naive PSCs.
Cell-surface marker screening
Antibody screening was performed on H9 PSCs cultured on feeders and feeder-free, with naive-state PSCs cultured in two different
conditions: 5i/L/FA and t2i/L+PKCi.
For 5i/L/FA cells, GFP-expressing primed and naive PSCs were dissociated into single cells with Accutase and passed through
40 mm cell strainer (BD Biosciences). For barcoding, primed PSCs were washed with PBS and the cell concentration was adjusted
to 1x106 cells/ml in prewarmed (37C) PBS. CellTrace Violet (ThermoFisher Scientific) was added to the cell suspension to obtain
5 mM solution and cells were incubated for 20min in a 37C water bath, protected from light. Cells were washed 3x with buffer
(2% FBS in PBS) and centrifugation at 300xg for 5min. 5i/L/FA-cultured naive PSCs and barcoded primed PSCs were combined
at a 1:1 ratio (3.5x106 cells each in 28ml buffer). 100 mL of cell mixture was aliquoted into V-bottom 96-well plates (BD Falcon)
and 20 mL of reconstituted antibodies were added to wells from Human Cell Surface Marker Lyoplates (BD Biosciences 560747)
and incubated for 20min on ice. Cells were washed 2x with buffer and centrifuged at 300xg for 5min. Secondary antibodies conju-
gated to Alexa Fluor 647 and diluted 1:200 with buffer were applied to the cells and incubated for 20min on ice. Cells were washed
2x with buffer and centrifuged at 300xg for 5min. Cells were resuspended in buffer with 1:200 7-AAD (BD Biosciences) and analyzed
with BD LSRFortessa cell analyzer (BD Biosciences).
For t2i/L+PKCi cells, primed and naive PSCs were maintained in feeder-free conditions and dissociated into single cells with Ac-
cutase. Cells were washedwith either primed or naive PSCmedia, collected by centrifugation at 300xg 5min and resuspended in Cell
Staining Buffer (BioLegend). Cells were passed through a 30 mm cell strainer (Sysmex) and the cell concentration was adjusted toCell Stem Cell 20, 1–17.e1–e7, June 1, 2017 e4
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Cell Screening 96-well plates (BioLegend 700001), containing 25 mL reconstituted PE-conjugated antibody. Plates were incubated
for 30 min at 4C protected from light. Plates were washed 2x with 200 mL Cell Staining Buffer per well, before final resuspension in
160 mL Cell Staining Buffer containing 1 mg/ml DAPI. Cells were analyzed using a BD LSRFortessa cell analyzer (BDBiosciences). The
antibody screen was performed in biological duplicate for naive and primed PSCs.
Flow cytometry
Primed and naive PSCs were dissociated into single cells with Accutase, washed and passed through 30-40 mm cell strainers. Con-
jugated antibodies were mixed with 50 mL Brilliant stain buffer (BD Biosciences) and applied to 50-100 mL of cells (2-5x105 cells per
reaction). Cells were incubated for 30min at 4C in the dark and washed 2x with buffer (2% FBS in PBS) and centrifuged at 300xg for
5min. Cells were resuspended in buffer with 7-AAD (BD Biosciences) or DAPI (Sigma) and analyzed with a BD LSRFortessa cell
analyzer (BD Biosciences) or a BD FACSAria Fusion for cell sorting. Single-stained cells or OneComp eBeads (eBioscience) were
used for compensation calculations. Unstained cells, GFP-expressing cells with 7-AAD, and FluorescenceMinusOne (FMO) controls
were used in cytometer and gating set up. Data was analyzed using FlowJo V10.1 software (FlowJo, LLC). Antibody details can be
found in Table S4.
Cell sorting was performed on day 10 transitioning cells. We noticed that the PKCi Go¨6983 produces a strong autofluorescent
signal, therefore, unstained H9 NK2 naive-state PSCs were used to setup the flow cytometer when sorting H9 NK2 transitioning cells
in order to provide a comparable fluorescence signal. Cells for continued culture were sorted directly into t2i/L+PKCi plus Y-27632.
Cells were cultured in the presence of Y-27632 for 12-24hr, and then media was replaced with t2i/L+PKCi. As there is no PKCi-medi-
ated autofluorescent signal in WIBR3 cultures, unstained WIBR3 primed-state PSCs were used to setup the flow cytometer when
sorting WIBR3 transitioning cells. Day 10 WIBR3 cells for continued culture were initially sorted into 5i/L/A media. Cell viability
was fine, but we noticed that cells failed to expand in number upon subsequent passages. We therefore sorted WIBR3 cells into
5i/L/FAmedia, which helped but failed to completely resolve this issue. In the end, we found that performing two-thirdmedia changes
substantially enhanced cell number expansion. Based on this, we recommend thatWIBR3 day 10 cells are sorted directly into 5i/L/FA
media, and after two passages, switch the media to 5i/L/A for continued culture using two-third media changes.
Table S5 shows information related to the setup of the flow cytometers including details of lasers, filters and fluorochromes.
FlowSOM analysis
FCS files were run through FlowAI V1.2.4, a quality control package that filters events affected by technical variation, such as abrupt
flow rate fluctuations (Monaco et al., 2016). Gating was performed in FlowJo V.10.1 (FlowJo, LLC). Subsequent analysis was per-
formed using FlowSOM (V1.2.0), an R bioconductor package that uses self-organizing maps for dimensional reduction visualization
of flow cytometry data (Van Gassen et al., 2015). All data was scaled and logicle transformed on import. Cells were assigned to a Self-
Organizing Map (SOM) with a 10x10 grid, which groups similar cells into 100 clusters. To visualize similar clusters aminimal spanning
tree (MST) was constructed and cell counts were log scaled.
For the time course experiments, live-human-gated cell populations from each day were exported. To account for cell number vari-
ation, an equal number of cells were exported for each time point. The same analysis was performed for the comparison of naive and
primed PSCs. For the analysis of cell sorted samples, the N4+, N3+ andN4- populations were additionally exported and visualized on
the minimal spanning tree (MST) constructed using all live human cells.
Immunofluorescent microscopy
Cells were fixed with 4% formaldehyde (Polysciences) for 15min and permeabilized with 0.3% Triton X-100 (Sigma) in PBS for 10min.
Cells were blocked with 5% donkey serum (Abcam), 1% BSA, and 0.1% Tween-20 (Sigma) in PBS for 1h. Primary antibodies were
applied for overnight at 4C. Cells were washed with 0.1%BSA, and 0.1% Tween-20 in PBS and secondary antibodies were applied
for 1h. Primary and secondary antibodies were diluted in 1% donkey serum, 0.1%BSA, and 0.1% Tween-20 in PBS. DNA was coun-
terstained with 1 mg/ml Hoechst 33342 (ThermoFisher Scientific) for 15min.
Human embryos were fixedwith 4% formaldehyde for 15min and permeabilizedwith 0.3%Triton X-100 in PBS for 10min. Blocking
was performed overnight at 4C in 4% FBS (ThermoFisher Scientific) and 0.1% Tween 20 in PBS. Embryos were incubated with pri-
mary antibodies overnight at 4C in blocking buffer, followed by 3x 5min washes in blocking buffer. Embryos were incubated with
secondary antibodies overnight at 4C in blocking buffer, followed by 3x 5min washes in blocking buffer, and 20min incubation
with 1 mg/ml Hoechst 33342. Embryos weremounted in blocking buffer between two coverslips using Secure-Seal adhesive spacers
(ThermoFisher Scientific).
Images were collected on a Zeiss LSM710-NLO point scanning confocal microscope with a 20x water immersion objective, and on
a NIKON A1-R confocal microscope with a 40x oil objective. Z stack images were processed with ImageJ (https://imagej.nih.gov/ij/).
Antibody details can be found in Table S4.
Western blotting
Whole cell lysates were extracted in RIPA buffer (Sigma) with 1x cOmplete Mini EDTA-free Protease Inhibitor Cocktail (Roche). Pro-
teins were separated by electrophoresis using 12% SDS-polyacrylamide gels and transferred to 0.45 mM PVDF membranes
(Amersham Hybond). Membranes were blocked for > 3h in TBS-T 5% milk and hybridized to primary antibody overnight at 4C.e5 Cell Stem Cell 20, 1–17.e1–e7, June 1, 2017
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secondary antibodies HRP-conjugated goat-anti-mouse, goat-anti-rabbit (1:5,000, Bio-Rad) or donkey-anti-goat (1:2,500, Jackson
ImmunoResearch) immunoglobulins. Detection was performed using Clarity Western ECL reagent (Bio-Rad). Primary antibodies:
TFCP2L1 (1:500, R&D Systems AF5726); KLF17 (1:200, Atlas Antibodies HPA024629); POU5F1 (1:500, Santa Cruz sc5279); b-ACTIN
(1:1000, Sigma A5441).
qPCR
For data in Figure S1, RNA was extracted using the RNeasy Mini Kit (QIAGEN), and 1 mg RNA was reverse transcribed using
SuperScript III (ThermoFisher Scientific) followed by quantitative PCR with Taqman universal master mix and Taqman assays
(ThermoFisher Scientific) using the StepOnePlus Real-Time PCRSystem (ThermoFisher Scientific). For data in Figure 6, cells isolated
by cells sorting went directly into TRIzol LS Reagent (ThermoFisher Scientific) and total RNA was extracted. RNA (1 mg) was reverse
transcribed using the QuantiTect Reverse Transcription Kit (QIAGEN), and quantitative PCR was performed using JumpStart Sybr
Green (Sigma). RNA from three or four biological replicates were used for each condition. For primer information, see Table S6.
RNA-sequencing
For RNA-sequencing, indexed libraries were constructed from 500ng total RNA using the NEBNext Ultra RNA Library Prep Kit for
Illumina with the Poly(A) mRNA Magnetic Isolation Module (NEB). Library fragment size and concentration was determined using an
Agilent Bioanalyzer 2100 and KAPA Library Quantification Kit (KAPA Biosystems). Samples were sequenced on an Illumina NextSeq
500 instrument as 150bp single-end libraries at the Babraham Institute Sequencing Facility.
RNA-sequencing reads were trimmed using trim galore v0.4.2 (http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/)
using default parameters to remove the standard Illumina adaptor sequence. Reads were mapped to the human GRCh38 genome
assembly using HISAT 2.0.5 (Kim et al., 2015) guided by the gene models from the Ensembl v70 release (Aken et al., 2017). Samtools
(Li et al., 2009) was used to convert to BAM files that were imported to Seqmonk v36.0 (http://www.bioinformatics.babraham.ac.uk/
projects/seqmonk/). Raw read counts per transcript were calculated using the RNA-sequencing quantitation pipeline on the Ensembl
v70 gene set using directional counts. Biological replicates were merged and differentially expressed genes were determined using
DESeq2 (Love et al., 2014). Regularised log transformation was applied prior to visualization to correct for library size and variance
among counts. PCA was performed using the top 1000 most variable genes across experimental condition. The first and second
principal components were plotted. Gene Ontology (GO) analysis for genes differentially expressed between N4+ and established
naive PSCs was performed using AmiGO 2 (Carbon et al., 2009) with default settings.
Transposable element analysis
To analyze the expression of transposable elements, probes were generated in SeqMonk over the locations of hg38 repeats and then
filtered to remove those which were within 2kb of a gene. Raw counts for all of the reads that overlapped with the final probe set were
exported and collated to generate counts for each class of repeat. Reads were globally normalized per million reads. Samples con-
taining > 3% reads outside of genes were discarded due to potential DNA contamination that could mask the quantification of trans-
posable elements. PCA was performed using the count data for repeat classes containing a minimum of 20 total reads across the
samples. The first and second principal components were plotted using the top 1000 most variable transposable elements across
experimental condition.
Quantification of X-linked genes
To analyze allele-specific expression of X-linked genes, an N-masked genome was generated using the positions of heterozygous
SNPs on the X chromosome of H9 cells (coordinates kindly provided byCeline Vallot (Vallot et al., 2015). RNA-sequencing readswere
trimmed using trim galore v0.4.2 and aligned to the N-masked genome using HISAT2 (default settings but without soft-clipping). The
mapped data was sorted into allele-specific reads using SNPsplit (v0.3.1, default parameters, single-end) (Krueger and Andrews,
2016). Genome1/genome2 reads, which corresponded to reads carrying either of the two SNPs, were imported into SeqMonk.
Probes were designed over informative SNP annotations (provided by Celine Vallot) and quantified in SeqMonk using linear read
counts. Read counts were exported as ‘Feature Report’ and annotated by gene name. Replicate samples were merged. Transcripts
with fewer than 10 informative readswere classified as ‘not expressed’. Transcripts were classified as biallelic when 25%–75% reads
originated from the minor allele (i.e., allelic ratio of 3:1).
QUANTIFICATION AND STATISTICAL ANALYSIS
qPCR analysis
Relative quantity was calculated with 2-DDCt using the average value of housekeeping genes GAPDH and RPLPO (data in Fig-
ure S1D) or GAPDH and HMBS (data in Figure 6C) for DCt and the value of primed PSCs for DDCt. Data are presented as
mean ± s.d. of 3 or 4 biological replicates. Statistical analysis was done using an ANOVA with Dunnett’s multiple comparison test
(GraphPad Prism 7). Significance was accepted with p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***). Statistical details are described
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In Figure 6D, data are presented as mean ± s.d. of 3 or 4 biological replicates. Statistical analysis was done using an ANOVA with
Dunnett’s multiple comparison test (GraphPad Prism 7). Significance was accepted with p < 0.05 (*), p < 0.005 (**), p < 0.0005
(***). Statistical details are described in Figure legends.
RNA-sequencing bioinformatics
Differentially expressed genes were identified using DESeq2 with a cut-off of p < 0.05 after multiple testing correction and without
independent filtering. For GO analysis, corrected p-values were calculated using a modified Fisher’s exact test followed by Bonfer-
roni’s multiple comparison test. Statistical details are described in Method Details and Figure legends.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA-seq data reported in this paper is GEO: GSE93241.e7 Cell Stem Cell 20, 1–17.e1–e7, June 1, 2017
